new formulations of Actonel and Fosamax and a new bisphosphonate called Reclast
June 2007
View the FDA's preliminary statement concerning bisphosphonates and atrial fibrillation
Drug companies will promote new formulations of Actonel and Fosamax and a new bisphosphonate called Reclast.
It's a competitive market. There are a huge number of potential patients...and big money is at stake.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote